Analyses of apoptosis and cell survival showed that CCR5 disruption markedly inhibited the protective effect of pericytes on GBM viability upon TMZ treatment (Fig. 5d; Supplementary information, Fig. S5f, g). Here, CCR5 is linked to glioblastoma.